Marlborough, MA, February 27, 2018 – Proveris Scientific announced today the spin-off of real-time, inhaler-specific voice guidance technology to Uneva Health, Inc. The technology is the core of a device/digital health platform Uneva Health is developing to reduce the enormous annual costs of inconsistent dosing caused by improper inhaler use while improving patient engagement and compliance. The platform includes a proprietary device that talks patients through inhaler use steps that are typically missed or done incorrectly, and mobile/web applications for viewing usage data.
“The platform will improve the safety and efficacy of marketed inhalers, and help ensure consistent dose delivery to millions of people suffering from asthma and COPD,” said Sue Farina, Uneva Health’s CEO and former Proveris President. “The opportunity to make a meaningful difference to help improve compliance and patient outcomes, while reducing healthcare costs is tremendous. Physicians and patients are anxiously waiting for the platform to be cleared for the market and see it as particularly helpful for pediatric and geriatric patient populations,” continued Farina.